Efficacy and safety of vildagliptin, sitagliptin, and linagliptin as add-on therapy in Chinese patients with T2DM inadequately controlled with dual combination of insulin and traditional oral hypoglycemic agent

Lignende værker

• Efficacy and safety of vildagliptin, Saxagliptin or Sitagliptin as add-on therapy in Chinese patients with type 2 diabetes inadequately controlled with dual combination of traditional oral hypoglycemic agents
  af: Li, Chun-Jun, et al.
  Udgivet: (2014)
• Repositioning of Hypoglycemic Drug Linagliptin for Cancer Treatment
  af: Li, Yong, et al.
  Udgivet: (2020)
• Testing the Therapeutic Equivalence of Alogliptin, Linagliptin, Saxagliptin, Sitagliptin or Vildagliptin as Monotherapy or in Combination with Metformin in Patients with Type 2 Diabetes
  af: Messori, Andrea, et al.
  Udgivet: (2014)
• Efficacy and Safety of Vildagliptin as an Add-On Therapy in Inadequately Controlled Type 2 Diabetes Patients Treated With Basal Insulin
  af: Saito, Daisuke, et al.
  Udgivet: (2017)
• In vitro cytogenetic assessment and comparison of vildagliptin and sitagliptin
  af: Börçek Kasurka, Ceren, et al.
  Udgivet: (2019)